Attorney John Gardella  was recently interviewed by Pat Rizzuto, reporter for Bloomberg Law, for her article regarding the proposed DuPont settlement in the AFFF MDL and 3M’s reported similar settlement for water utility cases on the MDL. Ms. Rizzuto is a Senior Chemicals’ Reporter for Bloomberg Law that has closely following and published on PFAS issues for several years. Ms. Rizzuto’s article takes a deep dive approach to examining the settlements, and whether they are truly as conclusory as many believe.

Two highlights from the article include:

“The two settlements would constitute the largest PFAS pacts in the US and one of the biggest mass tort deals ever. And they’d offer ‘the best path forward for getting some of these water utilities money relatively quickly that they need,’ said John Gardella, a shareholder, CMBG3 Law, LLC, who chairs the firm’s PFAS, Environmental, Risk Management & Consulting, and ESG practice group.”

“Final drinking water limits the Environmental Protection Agency is developing for up to six PFAS and the agency’s proposed designation of two of those chemicals—perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS)—as hazardous substances under the Superfund law are key drivers prompting utilities’ need for money, Gardella said.”

For the complete article and Ms. Rizzuto’s PFAS thought content, please visit Bloomberg News here:

https://news.bloomberglaw.com/environment-and-energy/pfas-settlements-of-11-billion-only-a-start-for-water-utilities

CMBG3 Law is following judicial, legislative, administrative, and scientific developments relating to PFAS. More information about the services we can provide, including risk assessments, to ensure your business is ready for any intersection with these substances can be found on our PFAS Litigation page.

Our attorneys have been at the forefront of PFAS issues, including giving presentations as to the future waves of litigation stemming from PFAS issues. For more information, please contact the Chair of our PFAS – Toxic Torts Team: John Gardella.